BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 16391861)

  • 21. Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2-M arrest.
    Gho JW; Ip WK; Chan KY; Law PT; Lai PB; Wong N
    Cancer Res; 2008 Aug; 68(16):6743-51. PubMed ID: 18701499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical impact of plasma TGF-beta1 and circulating TGF-beta1 mRNA in diagnosis of hepatocellular carcinoma.
    Dong ZZ; Yao DF; Yao M; Qiu LW; Zong L; Wu W; Wu XH; Yao DB; Meng XY
    Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):288-95. PubMed ID: 18522884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upregulation of ID protein by growth and differentiation factor 5 (GDF5) through a smad-dependent and MAPK-independent pathway in HUVSMC.
    Chen X; Zankl A; Niroomand F; Liu Z; Katus HA; Jahn L; Tiefenbacher C
    J Mol Cell Cardiol; 2006 Jul; 41(1):26-33. PubMed ID: 16716349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of suppression of TGF-beta1 expression on cell-cycle and gene expression of beta-1,4-galactosyltransferase 1 in human hepatocarcinoma cells.
    Zhang SW; Lin WS; Ying XL; Zhu D; Guo MY; Gu JX
    Biochem Biophys Res Commun; 2000 Jul; 273(3):833-8. PubMed ID: 10891333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transforming growth factor-beta1 is a negative modulator of adult neurogenesis.
    Wachs FP; Winner B; Couillard-Despres S; Schiller T; Aigner R; Winkler J; Bogdahn U; Aigner L
    J Neuropathol Exp Neurol; 2006 Apr; 65(4):358-70. PubMed ID: 16691117
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Id1 is a critical mediator in TGF-beta-induced transdifferentiation of rat hepatic stellate cells.
    Wiercinska E; Wickert L; Denecke B; Said HM; Hamzavi J; Gressner AM; Thorikay M; ten Dijke P; Mertens PR; Breitkopf K; Dooley S
    Hepatology; 2006 May; 43(5):1032-41. PubMed ID: 16628634
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mediation of the inhibitory effect of thyroid hormone on proliferation of hepatoma cells by transforming growth factor-beta.
    Yen CC; Huang YH; Liao CY; Liao CJ; Cheng WL; Chen WJ; Lin KH
    J Mol Endocrinol; 2006 Feb; 36(1):9-21. PubMed ID: 16461923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transforming growth factor-beta is an endogenous radioresistance factor in the esophageal adenocarcinoma cell line OE-33.
    Kim AH; Lebman DA; Dietz CM; Snyder SR; Eley KW; Chung TD
    Int J Oncol; 2003 Dec; 23(6):1593-9. PubMed ID: 14612931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extracellular matrix proteoglycan decorin-mediated myogenic satellite cell responsiveness to transforming growth factor-beta1 during cell proliferation and differentiation Decorin and transforming growth factor-beta1 in satellite cells.
    Li X; McFarland DC; Velleman SG
    Domest Anim Endocrinol; 2008 Oct; 35(3):263-73. PubMed ID: 18650056
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
    Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
    Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of expression of TGF-beta1, TbetaRI, and TbetaRII correlates with differentiation in human oral squamous cell carcinomas.
    Mincione G; Di Marcantonio MC; Artese L; Vianale G; Piccirelli A; Piccirilli M; Perrotti V; Rubini C; Piattelli A; Muraro R
    Int J Oncol; 2008 Feb; 32(2):323-31. PubMed ID: 18202754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concerted regulation of early enterocyte differentiation by insulin-like growth factor I, insulin, and transforming growth factor-beta1.
    Kojima H; Hidaka H; Matsumura K; Fujita Y; Nishio Y; Maegawa H; Haneda M; Yasuda H; Fujimiya M; Kikkawa R; Kashiwagi A
    Proc Assoc Am Physicians; 1998; 110(3):197-206. PubMed ID: 9625526
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tranilast inhibits hormone refractory prostate cancer cell proliferation and suppresses transforming growth factor beta1-associated osteoblastic changes.
    Izumi K; Mizokami A; Li YQ; Narimoto K; Sugimoto K; Kadono Y; Kitagawa Y; Konaka H; Koh E; Keller ET; Namiki M
    Prostate; 2009 Aug; 69(11):1222-34. PubMed ID: 19434660
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Id-1 promotes TGF-beta1-induced cell motility through HSP27 activation and disassembly of adherens junction in prostate epithelial cells.
    Di K; Wong YC; Wang X
    Exp Cell Res; 2007 Nov; 313(19):3983-99. PubMed ID: 17916352
    [TBL] [Abstract][Full Text] [Related]  

  • 35. TGF-β inhibits metastasis in late stage human squamous cell carcinoma of the skin by a mechanism that does not involve Id1.
    Ganapathy A; Paterson IC; Prime SS; Eveson JW; Pring M; Price N; Threadgold SP; Davies M
    Cancer Lett; 2010 Dec; 298(1):107-18. PubMed ID: 20663607
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Loss of functional transforming growth factor (TGF)-beta type II receptor results in insensitivity to TGF-beta1-mediated apoptosis and Epstein-Barr virus reactivation.
    Fukuda M; Kurosaki H; Sairenji T
    J Med Virol; 2006 Nov; 78(11):1456-64. PubMed ID: 16998876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activin A inhibits growth-inhibitory signals by TGF-beta1 in differentiated human endometrial adenocarcinoma cells.
    Tanaka T; Toujima S; Umesaki N
    Oncol Rep; 2004 Apr; 11(4):875-9. PubMed ID: 15010888
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Prohibitin suppresses renal interstitial fibroblasts proliferation and phenotypic change induced by transforming growth factor-beta1].
    Guo W; Xu H; Huang WY; Chen J; Yang Y; Fu R; Liu HM; Zha XL; Zhang ZG
    Zhonghua Yi Xue Za Zhi; 2007 Jun; 87(24):1660-5. PubMed ID: 17825142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Growth inhibition and gene induction in human hepatocellular carcinoma cell exposed to sodium 4-phenylbutanoate.
    Wang CT; Meng M; Zhang JC; Jin CJ; Jiang JJ; Ren HS; Jiang JM; Qin CY; Yu DQ
    Chin Med J (Engl); 2008 Sep; 121(17):1707-11. PubMed ID: 19024104
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of angiogenesis by Id-1 through hypoxia-inducible factor-1alpha-mediated vascular endothelial growth factor up-regulation in hepatocellular carcinoma.
    Lee TK; Poon RT; Yuen AP; Ling MT; Wang XH; Wong YC; Guan XY; Man K; Tang ZY; Fan ST
    Clin Cancer Res; 2006 Dec; 12(23):6910-9. PubMed ID: 17145808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.